Vascular Biogenics

+$0.06 (+2.87%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VBLT and other ETFs, options, and stocks.

About VBLT

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications.

CEO
Dror Harats
Employees
38
Headquarters
Modi’in, Jerusalem
Founded
2000

VBLT Key Statistics

Market Cap
164.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
299.53K
High Today
$2.16
Low Today
$2.10
Open Price
$2.14
Volume
222.35K
52 Week High
$3.17
52 Week Low
$1.01

VBLT Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure